Currently, Sanofi ADR [SNY] is trading at $53.02, up 2.26%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SNY shares have gain 4.78% over the last week, with a monthly amount drifted -5.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sanofi ADR [NASDAQ: SNY] stock has seen the most recent analyst activity on April 15, 2025, when Exane BNP Paribas initiated its Outperform rating and assigned the stock a price target of $65. Previously, Goldman started tracking the stock with Neutral rating on March 21, 2025, and set its price target to $65. On January 30, 2025, upgrade upgraded it’s rating to Hold. Argus reiterated its Buy rating and increased its price target to $60 on July 26, 2024. Morgan Stanley initiated its recommendation with a Equal-Weight and recommended $55 as its price target on January 23, 2024. In a note dated December 05, 2023, JP Morgan downgraded an Neutral rating on this stock.
This stock has fluctuated between a low of $45.80 and a high of $60.12 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $57.36 within the next 12 months. Sanofi ADR [NASDAQ: SNY] shares were valued at $53.02 at the most recent close of the market. An investor can expect a potential return of 8.19% based on the average SNY price forecast.
Analyzing the SNY fundamentals
Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.52 points at the first support level, and at 52.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 53.31, and for the 2nd resistance point, it is at 53.59.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sanofi ADR [NASDAQ:SNY] is 1.08. Also, the Quick Ratio is 0.73, while the Cash Ratio stands at 0.26. Considering the valuation of this stock, the price to sales ratio is 2.92, the price to book ratio is 1.66 and price to earnings (TTM) ratio is 22.14.
